Sfoglia per Autore
Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylase.
1994 R. Pellicciari;B. Natalini;G. Costantino;M. R. Mahmoud;L. Mattoli;B. M. Sadeghpour;F. Moroni;A. Chiarugi;R. Carpenedo
Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.
1994 R. Carpenedo; A. Chiarugi; P. Russi; G. Lombardi; V. Carlà; R. Pellicciari; L. Mattoli; F. Moroni
Synthesis and activity of enantiopure (S) (m-nitrobenzoyl) alanine, potent inhibitor of kynurenine hydroxylase.
1995 B. Natalini; L. Mattoli; R. Pellicciari; R. Carpenedo; F. Moroni; A. Chiarugi
Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase.
1995 A. Chiarugi;R. Carpenedo;M. T. Molina;L. Mattoli;R. Pellicciari;F. Moroni
KYNURENINE DISPOSITION IN BLOOD AND BRAIN OF MICE: EFFECTS OF SELECTIVE INHIBITORS OF KYNURENINE HYDROXYLASE AND OF KYNURENINASE
1996 A. CHIARUGI ; R. CARPENEDO; F. MORONI
Metoclopramide
1996 Alberto Chiarugi
Kynurenine hydroxylase and kynureninase inhibitors as tools to study the role of kynurenine metabolites in the central nervous system.
1996 F. Moroni;R. Carpenedo;A. Chiarugi
Sulpiride
1996 Alberto Chiarugi
Domperidone
1996 Alberto Chiarugi
IDENTIFICATION AND MEASUREMENT OF OXINDOLE (2-INDOLINONE) IN THE MAMMALIAN BRAIN AND OTHER RAT ORGANS
1997 R. CARPENEDO; V. CARLA'; A. CHIARUGI ; F. MORONI; G. MONETI
Studies on the pharmacological properties of oxindole (2-hydroxyndole) and 5-hydroxyndole: are they involved in hepatic encephalopathy?
1997 F. Moroni; R. Carpenedo; G. Mannaioni; A. Galli; A. Chiarugi; V. Carlà and G. Moneti
Studies on the pharmacological properties of oxindole (2-hydroxyindole) and 5-hydroxyindole: are they involved in hepatic encephalopathy?
1997 Moroni F;Carpenedo R;Mannaioni G;Galli A;Chiarugi A;Carlà V;Moneti G
Studies on the pharmacological properties of oxindole (2-hydroxyindole) and 5-hydroxyindole: are they involved in hepatic encephalopathy?
1997 F. Moroni; R. Carpenedo; G. Mannaioni; A. Galli; A. Chiarugi; V. Carlà; G. Moneti
Effects of mitochondria and o-methoxybenzoylalanine on 3-hydroxyanthranilic acid dioxygenase activity and quinolinic acid synthesis.
1999 A. Chiarugi;F. Moroni
The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound.
1999 A. Chiarugi; E. Rapizzi; F. Moroni Jr.; F. Moroni
Development and validation of a different pulse polarographic method for quinolinic acid determination in human plasma and urine after solid-phase extraction: a chemometric approach
1999 S. Furlanetto; S. Pinzauti; E. La Porta; A. Chiarugi; P. Maura; S. Orlandini
Regulation of quinolinic acid synthesis by mitochondria and o-methoxybenzoylalanine.
1999 A. Chiarugi;F. Moroni
Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.
1999 Chiarugi A;Moroni F
Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkB-dependent inducible nitric oxide synthase and cyclooxygenase-2
1999 V.CHIARUGI; L.MAGNELLI; A.CHIARUGI; O.GALLO
Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-gamma-activated macrophages.
2000 A.Chiarugi;P.Dello Sbarba;A.Paccagnini;S.Donnini;S.Filippi;F.Moroni
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile